Despite healthcare sector struggles, Vertex Pharmaceuticals has outperformed ... projecting an 8.2% jump in sales for 2025 as new products gain traction. The balance sheet tells an equally ...

Wall Street sees plenty of growth ahead, projecting an 8.2% jump in sales for 2025 as new products gain traction ... dollar markets, Vertex offers a compelling mix of stability and upside potential.

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

In a briefing document, the Department of Health said that it cannot currently control the price of a generic medicine if a manufacturer has a mix of branded and unbranded products, and the ...

In this feature, Grünenthal's Florent Edouard and Kate Hurtig outline their principles for a new pharmaceutical marketing ... excellence has been very product-driven. But that approach has ...